AF patients not anticoagulated at higher risk of death after TAVR
Individuals with atrial fibrillation (AF), diabetes, or low albumin levels are at increased risk of mortality following transcatheter aortic valve replacement (TAVR), with AF patients who are not anticoagulated being at greatest risk of dying, reveals a study.